RHBDF2 is correlated with immune infiltrates in hepatocellular carcinoma and may have potential as a biomarker

Immune checkpoint inhibitors have been approved for the treatment of advanced hepatocellular carcinoma (HCC). However, immunotherapy requires the identification of suitable biomarkers to guide treatment. The gene for rhomboid 5 homolog 2 (IRHom2), which encodes the rhombus protease iRhom2, activates...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Hanjuan, Xie, Hailun, Huangfu, Zhimin, Zhang, Shuxian, Tang, Yi, Xiao, Ming, Li, Ming, Wang, Yalan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153346/
https://www.ncbi.nlm.nih.gov/pubmed/36943228
http://dx.doi.org/10.1002/2211-5463.13598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153346/
https://www.ncbi.nlm.nih.gov/pubmed/36943228
http://dx.doi.org/10.1002/2211-5463.13598

Ejemplares similares